SEARCH OUR PRODUCT CATALOG

BICC1-FGFR2 Fusion FISH Probe

The BICC1-FGFR2 Fusion FISH Probe is used to confirm a fusion of the BICC1 and FGFR2 genes. The fusion of the BICC1 and FGFR2 genes has been associated with Cholangiocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
BICC1-FGFR2-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
BICC1-FGFR2-20-RERE 20 (40 μL) 200 μL
BICC1-FGFR2-20-REOR 20 (40 μL) 200 μL
BICC1-FGFR2-20-REGO 20 (40 μL) 200 μL
BICC1-FGFR2-20-REGR 20 (40 μL) 200 μL
BICC1-FGFR2-20-REAQ 20 (40 μL) 200 μL
BICC1-FGFR2-20-ORRE 20 (40 μL) 200 μL
BICC1-FGFR2-20-OROR 20 (40 μL) 200 μL
BICC1-FGFR2-20-ORGO 20 (40 μL) 200 μL
BICC1-FGFR2-20-ORAQ 20 (40 μL) 200 μL
BICC1-FGFR2-20-GORE 20 (40 μL) 200 μL
BICC1-FGFR2-20-GOOR 20 (40 μL) 200 μL
BICC1-FGFR2-20-GOGO 20 (40 μL) 200 μL
BICC1-FGFR2-20-GOGR 20 (40 μL) 200 μL
BICC1-FGFR2-20-GOAQ 20 (40 μL) 200 μL
BICC1-FGFR2-20-GRRE 20 (40 μL) 200 μL
BICC1-FGFR2-20-GROR 20 (40 μL) 200 μL
BICC1-FGFR2-20-GRGO 20 (40 μL) 200 μL
BICC1-FGFR2-20-GRGR 20 (40 μL) 200 μL
BICC1-FGFR2-20-GRAQ 20 (40 μL) 200 μL
BICC1-FGFR2-20-AQRE 20 (40 μL) 200 μL
BICC1-FGFR2-20-AQOR 20 (40 μL) 200 μL
BICC1-FGFR2-20-AQGO 20 (40 μL) 200 μL
BICC1-FGFR2-20-AQGR 20 (40 μL) 200 μL
BICC1-FGFR2-20-AQAQ 20 (40 μL) 200 μL

FGFR2 Gene Summary

The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]

Gene Name: Fibroblast Growth Factor Receptor 2

Chromosome: CHR10: 123237843 -123357972

Locus: 10q26.13

BICC1 Gene Summary

This gene encodes an RNA-binding protein that is active in regulating gene expression by modulating protein translation during embryonic development. Mouse studies identified the corresponding protein to be under strict control during cell differentiation and to be a maternally provided gene product. [provided by RefSeq, Apr 2009]

Gene Name: BicC Family RNA Binding Protein 1

Chromosome: CHR10: 60272903 -60588845

Locus: 10q21.1

Gene Diseases

The BICC1 FGFR2 Fusion has been associated with the following diseases:

Disease Name
Cholangiocarcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

FGFR2 amplification in colorectal adenocarcinoma

FGFR2 amplification occurs in about 5% of gastric cancers, but so far has only been reported in one colorectal cancer (CRC) cell line, where the cells were found to require FGFR2 amplification for survival. This was the first report of FGFR2 amplification in a CRC biopsy obtained directly from a patient’s primary tumor. Our FGFR2 FISH probe helped confirm FGFR2 amplification in the subject.